drug reps to give out information about unapproved uses of their prescription drugs
February 1999
The FDA will allow drug reps to give out information about UNAPPROVED uses of their prescription drugs.
Until now, drug reps could only give info about FDA-approved indications...even if their drug is commonly used "off-label."
That's why you've never seen a rep hand out info about verapamil for migraines...Neurontin for neuropathic pain...Wellbutrin for attention deficit disorder, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote